Nivolumab and ipilimumab shows a significantly higher OS rate in nccRCC compared to standard of care

Pembrolizumab shows improvement in overall survival for clear cell renal cell carcinoma

Irradiation plus ADT with GnRH antagonist vs. GnRH agonist shows similar efficacy in high risk locally advanced PC

Study shows association between tumour KIM-1 gene (HAVCR1) expression and immune infiltrates in RCC

Guiding metastasis-directed therapy with different PET/CT radiotracers affects distant disease control in HSPC patients

Bladder cancer updates from the second half of 2024

EMUC 2024: Optimising strategies in mHSPC and mCRPC